◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Hansoh Pharmaceutical Group Company Limited (3692) Financial History

Name: Hansoh Pharmaceutical Group Company Limited (3692) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Hansoh Pharmaceutical Group Company Limited (3692) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Shanghai, China with about 9,347 employees. Its market capitalization is roughly CNY 200 billion. In the fiscal year ended 2025-12-31, 3692 reported CNY 15.0B in revenue and CNY 5.6B in net income.

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China.

Interactive charts & full statements →

3692 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	CNY 15.0B	CNY 12.3B	CNY 10.1B	CNY 9.4B
Gross Profit	CNY 13.5B	CNY 11.2B	CNY 9.1B	CNY 8.5B
Operating Income (EBIT)	CNY 5.5B	CNY 4.0B	CNY 2.8B	CNY 2.8B
Net Income	CNY 5.6B	CNY 4.4B	CNY 3.3B	CNY 2.6B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3692 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 2.0B)	(CNY 1.9B)	(CNY 652M)	(CNY 712M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3692 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 39.9B	CNY 31.7B	CNY 33.0B	CNY 30.0B	—
Total Liabilities	CNY 4.5B	CNY 3.0B	CNY 7.2B	CNY 7.4B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3692 viewer.

3692 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion
4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion
4521 · Kaken Pharmaceutical Co., Ltd. — $151 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 3690 All “0-9” companies 3694 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.